Questa Capital

Questa Capital Management is a healthcare venture growth equity firm investing in breakout growth companies. Questa seeks out disruptive business models that improve lives and provide better quality and more efficient care. They partner with superior management teams to help build innovative market leaders. Questa Capital Management's mission is to generate outstanding returns for investors and management teams.

Butler, Brian L.

Vice President

Shawn Conway

COO

Ryan Drant

Founder and Managing Partner

Aabed Meer

Partner

Bradley Sloan

Managing Partner

43 past transactions

Bicycle Health

Venture Round in 2025
Bicycle Health is a virtual addiction medicine clinic that helps treat opioid dependence or use disorder. Addiction medicine specialists on the Bicycle Health platform will treat patients and works with the patient's insurance to get reimbursed for their services. The telemedicine-based company uses an interesting model to become an addiction medicine resource that physicians leverage for their patients while maintaining and strengthening their relationship with their patients. Ankit Gupta established it in San Francisco, California in 2017.

Aerin Medical

Venture Round in 2025
Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

Ossio

Series D in 2024
Ossio is an orthopedic fixation company dedicated to enhancing the orthopedic experience for patients, healthcare providers, and payors. Established in 2014, the company focuses on developing innovative alternatives to traditional metal implants in the orthopedic fixation market, which is valued at over $10 billion. Their flagship product, OSSIOfiber, utilizes Intelligent Bone Regeneration Technology, offering a biocomposite material that is designed to support the natural healing process. This breakthrough platform allows for secure fixation while enabling the body to regenerate bone tissue, effectively replacing the implant without leaving any permanent material behind. Ossio's technology addresses the limitations of conventional bio-resorbable materials, providing the necessary mechanical strength for easy insertion and stable fixation, while promoting better healing outcomes for patients with orthopedic disorders.

ACTO

Venture Round in 2024
ACTO is an AI-powered omnichannel education platform designed specifically for life sciences companies. It provides a comprehensive solution for field representatives by offering a single cross-platform app that combines mobile experiences with agency partnerships. The platform enables users to access essential information and training materials easily, ensuring brand message consistency through voice-enabled search for approved content. Additionally, ACTO equips leaders with powerful administrative tools that deliver engagement data, allowing for better oversight of field performance and the effectiveness of training initiatives. By streamlining access to crucial resources and enhancing communication, ACTO aims to empower life sciences organizations to improve the effectiveness of their field representatives.

Mindset Medical

Series A in 2024
Mindset Medical is a Health Care Company that develops a platform for clinical information. Through their platform physicians will understand patient pain, saves time for providers and patients, they eliminate paper and redundant forms, and allows providers more time for patients. Mindset Medical was founded in 2016 in Phoenix, Arizona.

SamaCare

Series B in 2024
SamaCare, Inc. is a technology company based in San Francisco, California, founded in 2017. It specializes in developing software that streamlines the prior authorization process for healthcare providers and pharmaceutical manufacturers regarding medically administered products. SamaCare's cloud-based workflow automation platform enhances the efficiency of specialty drug prior authorization, enrollment, and benefit verification, thereby helping medical practices navigate complex administrative tasks. The platform also includes features for building and submitting prior authorizations, as well as monitoring approvals and rejections, ultimately aimed at reducing the administrative burdens that can hinder patient care. Additionally, SamaCare offers premium services and data analytics to pharmaceutical brands, thereby improving access to essential therapies while ensuring compliance with regulations.

PocketHealth

Series B in 2024
PocketHealth is a cloud-sharing platform based in Toronto, Ontario, that facilitates the electronic sharing of medical imaging records between providers and patients. Founded in 2016, the platform allows patients to access their imaging results shortly after their scans and securely share this information with healthcare professionals, regardless of whether they are part of the PocketHealth network. By establishing a seamless and secure infrastructure, PocketHealth enhances the way sensitive medical imaging information is exchanged, improving accessibility and efficiency in patient care.

PatientFi

Venture Round in 2024
PatientFi, LLC operates a digital platform that facilitates financing for aesthetic medical procedures. Founded in 2017 and based in Irvine, California, the company allows patients to apply for credit online and collaborates with healthcare providers in elective sectors such as plastic surgery, dermatology, and dental care. Through its point-of-sale technology, PatientFi offers personalized financing plans, enabling patients to afford procedures like breast augmentation, mommy makeovers, and surgical facial rejuvenation. The company, previously known as PatientFirst Finance, aims to provide accessible financial solutions for those seeking health, beauty, and wellness treatments.

Avive

Venture Round in 2024
Avive Solutions is a company that develops an advanced Automated External Defibrillator (AED) aimed at improving survival rates from sudden cardiac arrest (SCA). Their device is designed to be portable, affordable, and user-friendly, ensuring that anyone can effectively respond to an SCA incident. In addition to the AED, Avive offers a connected software platform that facilitates the transfer of critical incident data to emergency services and healthcare professionals, enhancing the overall response to cardiac emergencies. By addressing the challenges associated with SCA, Avive Solutions aims to empower individuals and organizations to save lives more effectively. The company is based in Brisbane, California.

Calyxo

Series D in 2023
Calyxo, Inc. is a medical device company established in 2016 that specializes in innovative solutions for patients suffering from kidney stones, a condition that significantly impacts healthcare resources. The company has developed a vacuum-assisted retrieval device that allows for the efficient removal of multiple kidney stone fragments in a single insertion, offering a quick and effective procedure for healthcare providers. This device aims to enhance patient outcomes by ensuring a stone-free result, thereby streamlining the treatment process. Calyxo is led by a team of experienced professionals with a strong background in urology, united by a commitment to improving kidney stone care through technological advancements.

Free Market Health

Series B in 2023
Free Market Health, established in 2019 and based in Pittsburgh, PA, operates a care-driven marketplace aimed at simplifying the specialty medication fulfillment process. The company provides a platform that enhances the efficiency of referral distribution and reimbursement, helping payers and specialty pharmacies navigate the complexities of the healthcare market. By identifying value drivers and accountabilities for patient referrals, Free Market Health ensures that patients have timely access to essential medications. The company's focus on optimizing resources and maximizing opportunities ultimately prioritizes the needs of patients, facilitating better health outcomes in a challenging healthcare landscape.

Eximis Surgical

Venture Round in 2023
Eximis Surgical is developing an enabling technology that allows surgeons to quickly remove large specimens through small incisions. Its technology uses RF energized cutting wires temporarily held in place within a containment bag. It was founded in 2014 and headquartered in Louisville, Colorado.

Cortica

Series D in 2023
Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

DispatchHealth

Venture Round in 2022
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.

ACTO

Series B in 2022
ACTO is an AI-powered omnichannel education platform designed specifically for life sciences companies. It provides a comprehensive solution for field representatives by offering a single cross-platform app that combines mobile experiences with agency partnerships. The platform enables users to access essential information and training materials easily, ensuring brand message consistency through voice-enabled search for approved content. Additionally, ACTO equips leaders with powerful administrative tools that deliver engagement data, allowing for better oversight of field performance and the effectiveness of training initiatives. By streamlining access to crucial resources and enhancing communication, ACTO aims to empower life sciences organizations to improve the effectiveness of their field representatives.

Calyxo

Series C in 2022
Calyxo, Inc. is a medical device company established in 2016 that specializes in innovative solutions for patients suffering from kidney stones, a condition that significantly impacts healthcare resources. The company has developed a vacuum-assisted retrieval device that allows for the efficient removal of multiple kidney stone fragments in a single insertion, offering a quick and effective procedure for healthcare providers. This device aims to enhance patient outcomes by ensuring a stone-free result, thereby streamlining the treatment process. Calyxo is led by a team of experienced professionals with a strong background in urology, united by a commitment to improving kidney stone care through technological advancements.

Aerin Medical

Private Equity Round in 2022
Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

Proximie

Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.

Socially Determined

Series B in 2022
Socially Determined, Inc. develops a risk intelligence platform focused on social determinants of health (SDOH). Its primary offering, SocialScape, provides insights into social risks through a combination of social risk indices and visualizations derived from diverse data sources. This platform enables organizations, including health plans, providers, life science companies, and government agencies, to understand the dynamics of social risk and implement actionable programs aimed at enhancing health outcomes while reducing costs. Founded in 2017 and headquartered in Washington, D.C., Socially Determined utilizes secure, cloud-based technology to analyze and visualize community and individual SDOH risks, allowing clients to tailor their intervention strategies to address the specific needs of socially and clinically complex patients.

Bicycle Health

Series B in 2022
Bicycle Health is a virtual addiction medicine clinic that helps treat opioid dependence or use disorder. Addiction medicine specialists on the Bicycle Health platform will treat patients and works with the patient's insurance to get reimbursed for their services. The telemedicine-based company uses an interesting model to become an addiction medicine resource that physicians leverage for their patients while maintaining and strengthening their relationship with their patients. Ankit Gupta established it in San Francisco, California in 2017.

PocketHealth

Series A in 2022
PocketHealth is a cloud-sharing platform based in Toronto, Ontario, that facilitates the electronic sharing of medical imaging records between providers and patients. Founded in 2016, the platform allows patients to access their imaging results shortly after their scans and securely share this information with healthcare professionals, regardless of whether they are part of the PocketHealth network. By establishing a seamless and secure infrastructure, PocketHealth enhances the way sensitive medical imaging information is exchanged, improving accessibility and efficiency in patient care.

Avive

Series A in 2022
Avive Solutions is a company that develops an advanced Automated External Defibrillator (AED) aimed at improving survival rates from sudden cardiac arrest (SCA). Their device is designed to be portable, affordable, and user-friendly, ensuring that anyone can effectively respond to an SCA incident. In addition to the AED, Avive offers a connected software platform that facilitates the transfer of critical incident data to emergency services and healthcare professionals, enhancing the overall response to cardiac emergencies. By addressing the challenges associated with SCA, Avive Solutions aims to empower individuals and organizations to save lives more effectively. The company is based in Brisbane, California.

VyncaCare

Series C in 2022
VyncaCare provides palliative care, advanced care planning, and enhanced care management services.

Cortica

Series C in 2021
Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

Bicycle Health

Series A in 2021
Bicycle Health is a virtual addiction medicine clinic that helps treat opioid dependence or use disorder. Addiction medicine specialists on the Bicycle Health platform will treat patients and works with the patient's insurance to get reimbursed for their services. The telemedicine-based company uses an interesting model to become an addiction medicine resource that physicians leverage for their patients while maintaining and strengthening their relationship with their patients. Ankit Gupta established it in San Francisco, California in 2017.

Proximie

Series B in 2021
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.

Claritas Rx

Private Equity Round in 2021
Claritas Rx LLC is a digital health data company based in San Francisco, California, founded in 2011. It specializes in developing a platform that automates and integrates channel, commercial, and clinical data for biopharmaceutical manufacturers. The company focuses on providing data integration and analytics solutions that enable pharmaceutical companies to derive actionable insights into their commercial strategies and operational improvements. By leveraging its proprietary technology and extensive industry expertise, Claritas Rx aims to enhance the patient experience beyond clinical trials, helping manufacturers identify variables that influence patient access, treatment duration, and behavioral trends.

DispatchHealth

Series D in 2021
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.

Eko Health

Series C in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

ControlRad

Series C in 2020
ControlRad is focused on creating innovative solutions aimed at significantly reducing radiation exposure risks associated with both fixed and mobile C-arm procedures for patients and healthcare professionals. The company's devices are designed to minimize ionizing radiation during fluoroscopically guided interventional procedures, ensuring that image quality and workflow are not compromised. ControlRad employs an add-on solution for C-arms that utilizes an eye tracker and a tablet interface, allowing radiologists to achieve optimal image quality in the critical areas of interest while maintaining clarity in the surrounding regions. This approach enables healthcare providers to enhance patient safety without sacrificing the effectiveness of existing x-ray systems.

Aerin Medical

Venture Round in 2020
Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

DispatchHealth

Series C in 2020
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.

Eximis Surgical

Series A in 2020
Eximis Surgical is developing an enabling technology that allows surgeons to quickly remove large specimens through small incisions. Its technology uses RF energized cutting wires temporarily held in place within a containment bag. It was founded in 2014 and headquartered in Louisville, Colorado.

Cortica

Venture Round in 2020
Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

ControlRad

Series B in 2019
ControlRad is focused on creating innovative solutions aimed at significantly reducing radiation exposure risks associated with both fixed and mobile C-arm procedures for patients and healthcare professionals. The company's devices are designed to minimize ionizing radiation during fluoroscopically guided interventional procedures, ensuring that image quality and workflow are not compromised. ControlRad employs an add-on solution for C-arms that utilizes an eye tracker and a tablet interface, allowing radiologists to achieve optimal image quality in the critical areas of interest while maintaining clarity in the surrounding regions. This approach enables healthcare providers to enhance patient safety without sacrificing the effectiveness of existing x-ray systems.

andros

Series B in 2019
andros is an NCQA-certified Credentials Verification Organization and technology-enabled provider network management solutions company. The credentialing segment of the business combines software and services to help payers and provider organizations to eliminate compliance risk, streamline operations and manage their providers better. The Network Development segment of the business utilizes proprietary data sets, technology and subject matter expertise to build and manage provider networks that control costs, ensure compliance and deliver value for local, regional and national health plans.

DispatchHealth

Series B in 2019
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.

Barricaid

Series E in 2019
Barricaid is a medical device company that focuses on developing innovative solutions to prevent repeat disc herniation in patients who have undergone back surgery. The company's flagship product is a bone-anchored implant designed to reduce the likelihood of reherniation and the need for reoperation in cases involving large annular defects. This implant physically blocks the annulus at the surgical defect, enhancing the surgical outcome for patients at high risk of complications after lumbar discectomy. Composed of a titanium alloy, the device securely anchors into the vertebral body, either caudally or cranially, ensuring stability and effectiveness. By addressing the challenges associated with post-surgical recovery, Barricaid aims to improve patient outcomes and reduce the incidence of further surgeries related to sciatica.

Cortica

Venture Round in 2018
Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

Eximis Surgical

Venture Round in 2018
Eximis Surgical is developing an enabling technology that allows surgeons to quickly remove large specimens through small incisions. Its technology uses RF energized cutting wires temporarily held in place within a containment bag. It was founded in 2014 and headquartered in Louisville, Colorado.

DispatchHealth

Venture Round in 2017
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.

Medrio

Venture Round in 2017
Medrio, Inc. is a medical software company that specializes in web-based electronic data capture (EDC) solutions for clinical research applications. Founded in 2005 and based in San Francisco, California, with additional offices in Pune, India, and Paris, France, Medrio offers tools designed to support clinical trials across all phases, outcomes research, registries, and retrospective chart reviews. Its platform enables study sponsors and contract research organizations to efficiently design, configure, and manage clinical research projects, facilitating processes such as data collection, management reporting, and statistical analysis. Medrio's solutions are tailored to meet the needs of a diverse clientele, including pharmaceutical and biotechnology companies, academic research institutions, and clinical research organizations, all while emphasizing speed, cost-effectiveness, and ease of use.

EPIX Therapeutics

Venture Round in 2017
EPIX Therapeutics, Inc. is a medical device company based in Santa Clara, California, specializing in the development of advanced temperature-sensing irrigated radiofrequency ablation catheters for the treatment of atrial fibrillation and other cardiac arrhythmias. Utilizing its proprietary TempaSure technology, which incorporates microwave radiometry, EPIX Therapeutics provides precise real-time feedback on volumetric temperature during ablation procedures. This technology enables physicians to control and predict lesion formation more accurately, ultimately enhancing clinical outcomes for patients. Founded in 2007 and previously known as Advanced Cardiac Therapeutics, EPIX Therapeutics has formed strategic partnerships with industry leaders such as Abbott Laboratories and Hansen Medical Inc. The company operates as a subsidiary of Medtronic plc, focusing on improving the treatment of irregular heart rhythms through its innovative catheter-based systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.